PARATEK PHARMACEUTICALS

Lobbying for PARATEK PHARMACEUTICALS · Pharmaceuticals - Antibiotics & Biodefense

Filing Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Sep 29, 2025

Expenses

$20,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 4

Defense, Dept of (DOD)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Budget/Appropriations

FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.